Bisaya News: Greenrise Global’s Medical Cannabis Subsidiary, AMP Alternative Medical Products GmbH becomes Exclusive Distribution Partner of a Selection of Little Green Pharma Extracts in Germany

Hamburg, Germany and PERTH, Australia, January 18, 2022 /CNW/ – Greenrise Global Brands Inc. (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise Global”), a distributor of medical and CBD wellness cannabis products in Germany announces that its wholly owned subsidiaries AMP Alternative Medical Products GmbH (“AMP”) and Little Green Pharma Ltd. (ASX: LGP) (“LGP”), a vertically integrated cannabis manufacturer, has appointed AMP as marketer and distributor of LGP medicinal cannabis extracts to pharmacies and clinics in Germany, including the exclusive distributor of LGP’s 20:5 LGP Classic and 10:10 LGP Classic extract oils.

Greenrise Global Logo (CNW Group/Greenrise Global Brands Inc.)

AMP has entered into a three-year exclusive pharmaceutical distribution agreement for LGP Classic whole plant cannabis extract oils. LGP medicinal cannabis products have been registered for sale with the relevant authorities in Germany Germany and include 20:5 LGP Classic and 10:10 LGP Classic extract oils in 30 and 50 milliliter sizes. Doctors and pharmacists can find more information about the product or order it on the AMP website: https://amp-eu.com/doccheck-login.

LGP is a pioneer and market leader in the manufacture of medicinal cannabis extract oils using GMP cultivation facilities in Australia and Denmark, whose medicinal cannabis preparations offer various THC and CBD profiles, available as LGP Classic medicinal cannabis oil. LGP medicinal cannabis oils are made from a whole plant extract (full spectrum) together with medium chain triglyceride (MCT) oil. LGP was one of the first medicinal cannabis companies to produce and export medicinal cannabis oil Germany and continues to build its reputation Europe by being selected as the primary supplier of medicinal cannabis extract oil in of France two-year medical cannabis studies conducted by the French National Agency for the Safety of Medicines and Health Products (L’Agence national de sécurité du medicament et des produits de santé, or ANSM).

The story goes on

Medical cannabis extract oils from LGP are also to be used in a clinical study by the Waldhausklinik Deuringen gGmbH (“Waldhausklinik”) for the therapeutic use of cannabis extracts with a focus on pain therapy in patients with multilocular chronic pain. The Waldhausklinik is a non-profit acute hospital for internal medicine in the Free State of Bavaria and has entered into a research cooperation with AMP on the effectiveness and safety of medical cannabis.

DR Stephen Flintstone, President and Director of Greenrise Global and Managing Director of AMP, commented, “We see the industry maturing with the growth of pharmaceutical cannabis products via flowers and are excited to add LGP medicinal cannabis extracts to our portfolio.”

MS. Fleta Solomon, Managing Director of Little Green Pharma, commented, “We have a strategic goal to be one of the premier manufacturers and distributors of medicinal cannabis extract in the United States Europe, meaning to be a leader in Germany, the largest medicinal cannabis market in the world. Our partnership with Greenrise Global’s subsidiary, AMP Alternative Medical Products GmbH, puts us on this path.”

About Little Green Pharma
Little Green Pharma is a global, vertically integrated and geographically diversified medical cannabis and psychedelics company with activities from cultivation and production to manufacturing and distribution.

The Company has two global manufacturing facilities for the manufacture of its own branded and white label range of GMP quality medical cannabis products namely a 21,500m2 cultivation u 4,000m2 GMP production facility capable of producing over 20 tons of medicinal cannabis biomass per year is located in Denmark (EU) and an indoor cultivation and production facility in Western Australia able to produce ~3 tons of biomass for medicinal cannabis per year. The company is also licensed to supply psilocybin and is currently expanding its manufacturing facilities in WA to manufacture psilocybin medication.

Little Green Pharma’s cannabis products meet all the requirements of the Danish Medicines Agency and the Therapeutic Goods Administration (Australia) regulations and test requirements. With a growing range of products with varying levels of active ingredients, Little Green Pharma supplies medicinal cannabis products to the Australian, European and overseas markets.

The Company has a strong focus on patient access in the emerging global medicinal cannabis market and is actively engaged in advancing education and awareness programs and participating in clinical trials and research projects to develop innovative new delivery systems.

For more information about Little Green Pharma, please visit: www.littlegreenpharma.com

Twitter: https://twitter.com/LittleGreenPHAR
LinkedIn: https://www.linkedin.com/company/little-green-pharma
Facebook: https://www.facebook.com/littlegreenpharma

About Greenrise Global Brands

Greenrise Global helps people see the beneficial properties of cannabis. Greenrise Global is a publicly traded Canadian company with two subsidiaries operating in Germany: Greenrise GmbH (“Greenrise Wellbeing”) and AMP Alternative Medical Products GmbH (“AMP”). Greenrise Wellbeing is a CBD wellness company based in Hamburg, with brands like Herbify and CANAVEX® in its portfolio.

AMP Alternative Medical Products GmbH, based in Erfurt, supplies pharmacies throughout Germany with medical cannabis products Germany, including medicinal cannabis brands from Aphria, Bedrocan, Little Green Pharma and AMP’s branded line of products sold through its nationwide sales team. AMP complies with the German Narcotics Act (BtMG) and the regulatory requirements of the Free State of Thuringia and ensures that products are imported and sold from all over the world Germany meet the Good Manufacturing Practice (EU-GMP) standard of the European Union.

For more information about Greenrise Global, visit www.greenriseglobal.com

Twitter: https://twitter.com/GreenriseGlobal
LinkedIn: https://linkedin.com/company/greenriseglobal/
Instagram: https://www.instagram.com/greenriseglobal/

Neither the CSE nor its Regulation Service Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this press release.

This press release contains forward-looking statements based on the Company’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including regarding its business plans and milestones and the timing thereof. Although the Company believes that the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. As a result, actual consequences and results could differ materially from those projected in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to publicly update them to reflect new information or the occurrence of future events or circumstances, except as required by law.

AMP logo (CNW Group/Greenrise Global Brands Inc.)